Ovoca Bio | OVG - Des Atouts





Des Atouts Changement Date
Akebia Therapeutics USD 362.52M 14.04M 2026-03
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
ALKERMES USD 4.39B 135.05M 2026-06
Avita Medical AUD 56.39M 1.74M 2025-12
Dianthus Therapeutics USD 1.25B 715.96M 2026-03
Great Western Mining Corporation EUR 9.91M 801.61K 2025-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
Malin Corporation EUR 198.5M 70.1M 2024-12
Moderna USD 10.96B 527M 2026-06
Organon & Co USD 13B 129M 2026-03
Ovoca Bio EUR 1.66M 9.75M 2025-06
Revvity USD 12B 171.82M 2026-03
Tectonic Therapeutic USD 246.58M 14.46M 2026-03
Viatris USD 36.83B 358.5M 2026-03
Xeris Pharmaceuticals USD 392.01M 8.49M 2026-03